High dose NTG vs low dose NTG in the management of Sympathetic Crashing Acute Pulmonary Edema(SCAPE)
Not Applicable
- Conditions
- Health Condition 1: R098- Other specified symptoms and signsinvolving the circulatory and respiratory systemsHealth Condition 2: I999- Unspecified disorder of circulatory system
- Registration Number
- CTRI/2021/11/037902
- Lead Sponsor
- Department of Emergency Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Adults ( more than or equal to 18 years ) presenting to ED with
1.BP more than or equal to 160/100 mmHg
2.Acute shortness of breath (within 6 hrs )
3.Respiratory Rate more than or equal to 30/min
4.SpO2 less than or equal to 90%
5.Bilateral crepitations in all pulmonary areas
2)Patients / Legally authorised representative willing to give valid consent
Exclusion Criteria
1)Patients / Legally authorized representative unable or unwilling to give informed consent.
2)Patients brought in Cardio- Respiratory Arrest
3)History of trauma
4)Age less than 18 years
5)Patients with associated ACS
6)History of hypersensitivity to NTG
7)Use of Phosphodiesterase V inhibitors within 48 hours
8)Patients with moderate to severe AS, HOCM
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method